Fraunhofer Institute for Toxicology and Experimental Medicine

Excellent stage for excellent research!

Fraunhofer ITEM is a part of the nationwide campaign “Hannover – city of excellence”

more info

Cluster of Excellence for Immune-Mediated Diseases CIMD

By teaming up with Fraunhofer IME, Fraunhofer IZI and other partners, we aim to advance the translation of innovative ideas and identified targets into individualized therapies for immune-mediated diseases.

more info

New guidance for endocrine disruptors and biocides

We support our clients concerning the compilation of data for the evaluation of the endocrine potential of biocides.

more info

Gentle treatment for premature babies

Researchers at Fraunhofer ITEM are working on an intelligent inhalation system for babies with lung diseases.

more info

Australian researchers explored the German healthcare sector

On November 8, 2018, 16 Australian researchers visited Fraunhofer ITEM as part of the InnoTour 2018.

more info

MDR – handicap for the innovation hotspot Germany

High-Performance Center Translational Biomedical Engineering is suggesting specific measures for a revision of the Medical Device Regulation.

more info

Chip-based cell analysis by chip cytometry

New technology at Fraunhofer ITEM enables sputum analysis by chip cytometry.

more info

Project EU-ToxRisk

Fraunhofer ITEM scientists will test new approach methodologies for animal-free toxicity testing and risk assessment

more info

Fraunhofer ITEM: News

News / 11.4.2019

RespiraTox

A QSAR-based model ist now available as a user-friendly online application and prediction tool. Register now!

News / 5.4.2019

Excellent stage for excellent research!

Fraunhofer ITEM is a part of the nationwide campaign “Hannover – city of excellence”.

News / 28.3.2019

“Taster Day” 2019

A total of 23 pupils visited Fraunhofer ITEM for one day with lots of questions and gained interesting insights into our work.

News / 22.3.2019

Environmental Chemistry and Ecotoxicology

Fraunhofer ITEM expert Dr. Stefan Hahn is now chairman of a division of the German Chemical Society.

 

Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0

Events

21.10.2019

Endocrine disruptors

The objective of this training course is to enable the understanding and practical implementation of the guidance document on ED hazard identification of plant protection products in the context of the EU legislation on pesticides amongst members of EFSA’s Scientific Committee/Panels, their working groups as well as EFSA staff.
Read more

6.5.2019

Principles of genotoxicity in scientific assessment

This training course will give guidance to participants on how to evaluate study data on genotoxicity and how to integrate corresponding testing results in risk assessment.
Read more

13.4.2019

ECCMID 2019

On April 13, 2019, Fraunhofer ITEM scientist Dr. Sabine Wronski will present her recent research work at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam, Netherlands.
Read more

9.4.2019

3rd Joint Symposium on Nanotechnology

The Fraunhofer-Gesellschaft and the German Federal Institute for Risk Assessment (BfR) invite you to their 3rd Joint Symposium on Nanotechnology, taking place in spring 2019. This time, the symposium will be hosted by the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.
Read more

Our services and expertise

 

Drug Development

From drug candidate to proof of concept

 

Chemical Safety and Assessment

From risk analysis towards safe products

 

Translational Biomedical Engineering

From idea to safe medical device

 

Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM